Find Academic Supervisors

Dilara PerverView profile

Lecturer

• Hematology
• Biomedical Engineering
• Stem Cell Biology
• +5 more

Dr. Dilara Perver is a Lecturer and Jr. Group Leader at ETH Zürich, affiliated with the Department of Health Sciences and Technology and the Institute of Translational Medicine. She holds a Dr. Sc. ETH Zürich, complemented by M.Sc. degrees in Biology and Chemistry from Hacettepe University (Turkey). Her research focuses on ex-vivo technologies for immuno-cellular therapies targeting hematological malignancies, predictive microphysiological models for leukemia/lymphoma, and development of bioreactors for stem cell expansion. She has authored numerous peer-reviewed articles and book chapters, with a particular emphasis on bone marrow niche engineering and extracellular matrix dynamics. Key professional milestones include a postdoctoral role at ETH Zürich, an internship at Novartis in CAR-T cell therapy development, and leadership roles in academic associations like AVETH and the Scientific Staff Association of Health Sciences and Technology. She has secured grants such as the TÜBİTAK Doctoral Research Grant (USD 120,000) and the National Graduate Student Prestige Scholarship. Her work bridges biomaterials, stem cell biology, and clinical translation, with implications for regenerative medicine and oncology. Dr. Perver is actively involved in teaching and science communication, having completed training in project management, entrepreneurship, and clinical trial design. Her contributions to interdisciplinary research and innovation are further highlighted by her memberships in societies like the International Society for Stem Cell Research (ISSCR) and the European Society for Blood and Marrow Transplantation (EBMT).

Mandy Brigitte EschView profile

Assistant Professor

• Microphysiological Systems
• Organ-on-a-Chip
• Drug Toxicity Testing
• +2 more

Mandy Brigitte Esch is an Assistant Professor in Cornell University's Department of Biomedical Engineering. Her research develops microphysiological systems (organ-on-a-chip) to model human physiology for drug testing applications. This work aims to reduce animal testing through advanced in vitro models. Research innovations include: Pumpless microfluidic platforms for multi-tissue co-culture Body-on-a-chip systems with physiological blood surrogate circulation Organ-specific vasculature models Her laboratory focuses on standardizing microphysiological systems for drug development pipelines while improving physiological relevance of in vitro models. Applications span pharmacology, toxicology, and disease modeling with publications in Lab on a Chip, Nature Protocols, and Advanced Healthcare Materials.

Vladimir A. PozdinView profile

Assistant Professor

• Wearable health monitoring
• In-situ sensing
• Flexible electronics
• +3 more

Vladimir A. Pozdin is an Assistant Professor in the Department of Mechanical and Materials Engineering at Florida International University (FIU). He holds a secondary appointment within the university and is actively involved in research and academic leadership. His work focuses on advanced materials and wearable technologies with applications in healthcare monitoring and biomedical engineering. Research Interests: Wearable health monitoring systems In-situ sensing for medical diagnostics Flexible electronics integration Microphysiological systems modeling Light-responsive materials for biomedical applications His research emphasizes developing innovative wearable devices for real-time health tracking, including systems like wireless functional near-infrared spectroscopy for cognitive monitoring and smart wound dressings. He also explores microphysiological systems to model biological barriers and study cellular responses under hypoxic conditions. His work intersects materials science, biomedical engineering, and clinical applications, with a focus on translating lab innovations into practical healthcare solutions. Publications Trends: Recent articles highlight advancements in wearable sensor design, light-controlled peptide ligands for protein purification, and microfluidic models for tissue engineering. These studies often bridge organic electronics, molecular engineering, and clinical diagnostics to address unmet needs in personalized medicine and regenerative therapies. Awards & Recognition: No scientific awards explicitly mentioned in the provided texts. Advising & Grants: Details on student advising and funded grants are not available in this dataset. However, his involvement with initiatives like the CELL-MET and PATHS-UP Engineering Research Centers (ERCs) suggests participation in collaborative, industry-linked projects. Labs & Teams: Affiliated with FIU’s CELL-MET ERC (Cellular Microphysiological Models for Engineering and Toxicology) and PATHS-UP ERC (Personalized Advanced Therapeutic and Health Solutions Using Microphysiological Systems), focusing on translating microphysiological research into clinical and industrial applications.

Lisa A. DeLouiseView profile

Associate Professor

• Nanomaterial Toxicology
• Skin Immunology
• Environmental Health
• +6 more

Lisa A. DeLouise, Ph.D., M.P.D., is an Associate Professor in the Departments of Dermatology, Biomedical Engineering (joint appointment), and Electrical & Computer Engineering (joint appointment) at the University of Rochester. Her research focuses on nanomaterial toxicology, skin immune responses, and developing microphysiological systems for drug discovery. She leads the DeLouise Bio-nanomaterials Lab, which investigates nanoparticle interactions with skin and environmental pollutants, as well as tissue chip technologies for high-throughput screening. Education: Ph.D. in Physical Chemistry, Penn State University (1984) M.P.D. in Product Development, Rochester Institute of Technology (2001) B.S. in Chemistry, Providence College (1979) Research Interests: Environmental impacts of nanomaterials/microplastics on skin health Nanoparticle modulation of immune responses in allergic dermatitis Salivary gland tissue chip development for radioprotection drug screening Microbubble array technology for single-cell analysis and antibody discovery Lab Members: Includes graduate students and researchers working on projects such as organ-on-a-chip systems, microplastic toxicity models, and cancer stem cell sorting using microbubble arrays. Current trainees include Hossein Abolhassani, Alma Avila Oropeza, Chiao Yun Chen, and others. Funding: Supported by grants from the NIH/NIAID, NSF, UR CTSI, and NYSTAR. Active collaborations with organizations like Nidus MB Technologies for commercializing microbubble array technology. Lab Locations: MC 5-6100, 601 Elmwood Ave, Rochester, NY. Contact: Lisa_DeLouise@urmc.rochester.edu | (585) 275-1810

Bruce BunnellView profile

Professor

• Regenerative Medicine
• Stem Cells
• Tissue Engineering
• +2 more

Bruce Bunnell is Professor and Chairman of the Department of Microbiology, Immunology & Genetics at the University of North Texas Health Science Center's College of Biomedical and Translational Sciences. His research program focuses on regenerative medicine, stem cells, and tissue engineering, particularly using mesenchymal stem cells (MSCs) for therapeutic applications in immune diseases, wound repair, and bone regeneration. Research Focus: Investigating adipose-derived stem cells for osteoarthritis, multiple sclerosis, and lipedema treatment; developing microphysiological systems for human knee modeling; engineering tissues using decellularized scaffolds. Technical Expertise: Stem cell isolation/organoid culture, molecular analyses, microphysiological system development, and preclinical translation. Recent Research Trends: Publications focus on breast cancer microenvironment (particularly triple-negative), obesity-cancer interactions, stem cell-based regenerative approaches, and advanced 3D disease modeling techniques.

• Hepatology
• Cholestasis
• Liver Diseases
• +6 more

James Lorenzen Boyer is the Ensign Professor of Medicine and Emeritus Director of the Yale Liver Center at Yale School of Medicine. He holds a MD from Johns Hopkins University (1962) and completed residency and fellowship training at Yale. His research focuses on hepatobiliary transport mechanisms, bile formation, and cholestatic liver diseases. He pioneered studies on bile acid-induced inflammation and developed organoid models for liver disease. Boyer is a leader in the field, having founded the NIDDK-funded Yale Liver Center and served as president of the American and International Associations for the Study of Liver Disease. His awards include the 2020 European Association for the Study of the Liver International Recognition Award and NIH MERIT Award. He has contributed to over 200 publications, advancing therapies for cholestasis and autoimmune liver diseases. Current research includes bile acid signaling, biliary organoid drug discovery, and mechanisms of cholestatic injury. Clinical interests span autoimmune hepatitis and primary biliary cholangitis. Education: Haverford College (Biology, 1958), Johns Hopkins School of Medicine (MD, 1962) Leadership: Past Chair of American Liver Foundation Board, Mt Desert Island Biological Laboratory Board Key contributions: Discovered canalicular membrane transporters, developed hepatocyte couplet model, identified bile duct organoid applications

Alice WhiteView profile

Professor

• Optical Device Fabrication
• Electronic Packaging
• Additive Manufacturing
• +4 more

Alice White is a Professor affiliated with the College of Engineering and Department of Mechanical Engineering at Boston University. She holds affiliations with the Division of Materials Science and the Photonics Center. Her research focuses on fabrication and packaging of optical and electronic devices, including novel optical devices for future exabit networks, additive manufacturing via high-resolution 3D printing, and silicon photonics integration using CMOS processes. Recent work includes neural interface devices and biocompatible microelectrodes. Education: PhD in Engineering from Harvard University. Professional roles emphasize interdisciplinary collaboration across materials science, photonics, and biomedical engineering. Research interests span optical device innovation, nanoscale fabrication, and biomedical microdevices. Recent publications highlight advancements in cardiac tissue engineering, programmable microrobots, and metamaterial scaffolds. Over 50 peer-reviewed articles demonstrate expertise in photonics, additive manufacturing, and biocompatible systems.

• Stem Cell Biology
• Neuroscience
• Virology
• +5 more

Bas Lendemeijer is a Researcher at Erasmus MC, affiliated with the Department of Psychiatry. His work focuses on stem cell biology, neuroscience, virology, and medical research. He completed his doctoral thesis in 2021, titled 'Leveraging human induced pluripotent stem cells for modeling brain diseases.' His research includes studying astrocyte functionality derived from pluripotent stem cells, standardizing microphysiological systems, and investigating SARS-CoV-2 variants' neurovirulence. Lendemeijer's contributions span both in vitro and in vivo models to explore cellular mechanisms and disease pathways. His recent work emphasizes translational research, aiming to bridge stem cell technologies with clinical applications in neurology and psychiatry.

• Stem Cell Biology
• Cardiac Physiology
• Regenerative Medicine
• +3 more

Mari Pekkanen-Mattila is a University Lecturer in Biomedical Technology at Tampere University, affiliated with the Faculty of Medicine and Health Technology and the Department of Biomedical Technology. She holds a Doctor of Philosophy from Tampere University (2011). Her research focuses on stem cell-derived cardiomyocytes, cardiac tissue engineering, and microphysiological systems for modeling heart physiology and pathophysiology. Key contributions include developing biomaterial-based cardiac models and investigating electrophysiological responses in cardiomyocytes under stress conditions. She received the Teaching achievement award in the Faculty of Medicine and Health Technology (2021) and has contributed to datasets such as a portable microscale cell culture system. Pekkanen-Mattila has presented at international conferences on topics like biomaterials for cardiac disease modeling and 3D in vitro neural-cardiac models. She also holds an academic qualification in university pedagogy (2012).

TomerView profile

Professor

• Neuroscience
• Neuroengineering
• Molecular Biology
• +3 more

The Tomer Lab at Columbia University is led by Professor Tomer , a pioneer in developing advanced molecular and optical methods for multi-scale biological research. The lab focuses on Neuroscience , Neuroengineering , and Neuropsychiatric Disorders , with innovations such as the Modular Neuronal Network (MoNNet) platform for non-invasive brain modeling and Light Sheet Microscopy variants (COLM, LSTM, pLSM, SPED) for high-resolution neuroimaging. Research Highlights: MoNNet for in vitro modeling of adult brain networks COLM and SPED for rapid whole-brain mapping LSTM and pLSM for light sheet imaging advancements PrImR software for cellular gene expression analysis Key Publications span 3D brain culture techniques, high-speed microscopy, and ketamine's neurobiological effects, with recent articles in Nature Biomedical Engineering , Nature Communications , and Cell Reports . The lab collaborates with MBF Bioscience for commercializing technologies like ClearScope. Grants & Collaborations: SBIR Grant (2020, 2024) for ClearScope development UG3/UH3 NCATS Grant for cerebral organoid-blood vessel systems Irving Institute Collaborative Award for light sheet microscopy Training & Innovation: The lab mentors graduate researchers like Bianca, Malika, and Iden (NSF Fellow), and has produced multiple preprints, patents (e.g., Light Sheet Theta Microscopy), and open-source tools. Their work bridges Neurotechnology with Translational Neuroscience for drug discovery and disease modeling.

Adam Roger HallView profile

Associate Professor

• DNA Nanotechnology
• Innate Immunity
• Cancer Biomarkers
• +4 more

Adam Roger Hall serves as Associate Professor in Biomedical Engineering at Wake Forest University School of Medicine with cross-appointments at the Wake Forest Institute for Regenerative Medicine, Center for Redox Biology and Medicine, and Comprehensive Cancer Center. His research integrates nanotechnology with biomedical diagnostics and therapeutic development. Dr. Hall's educational background includes: BS from University of North Carolina, Chapel Hill (2002) PhD from University of North Carolina, Chapel Hill (2007) His research focuses on DNA nanotechnology applications for cancer biomarker detection and innate immunity studies, utilizing solid-state nanopores and microfluidic systems. Key areas include: Cancer Biomarker Discovery Glycan Analysis Nanopore-Based DNA Sensing Microfluidic Drug Screening Platforms Epigenetic Modification Studies Translational Cancer Diagnostics Recent publications (2020-2021) demonstrate consistent innovation in nanotechnology applications, particularly solid-state nanopore techniques for DNA analysis in cancer detection, affinity-labeling methods for epigenetic studies, and biomaterial development for organ-on-a-chip systems. Dr. Hall actively participates in the Biomedical Engineering PhD Program and Biomedical Engineering Society, contributing to graduate education and professional development within the department. His laboratory work integrates with multiple research centers including the Wake Forest Institute for Regenerative Medicine where he develops tissue engineering solutions, and the Comprehensive Cancer Center where his nanopore technologies advance early cancer detection methodologies.

Hanne Røberg-LarsenView profile

Associate Professor

• Bioanalytical Chemistry
• Liquid Chromatography–Mass Spectrometry (LC-MS)
• Oxysterol Analysis
• +6 more

Hanne Røberg-Larsen is an Associate Professor at the University of Oslo, positioned within the Section for Chemical Life Sciences – Biomolecules, Bio-Inspired Materials and Bioanalytical Chemistry. Her work sits at the intersection of advanced analytical chemistry and biomedical research, where she develops and applies cutting-edge LC-MS technologies to address complex biological questions. Research Focus: Bioanalytical method development using nano- and capillary-LC–MS Oxysterol biology and lipid signalling in cancer and metabolic disease Single-cell and ultra-small sample omics Organoid and organ-on-chip analytics Automated sample preparation and microfluidic integration Across more than 40 peer-reviewed papers (2012-2025), her group has progressively pushed sensitivity limits for detecting metabolites, hormones and drugs in miniaturised systems. Recent trends reveal a strong emphasis on in vitro microphysiological models—combining organoids, organ-on-chip devices and tailored LC-MS workflows—to study metabolic crosstalk and therapeutic responses under controlled conditions. Particular attention is given to cholesterol-derived signalling molecules (oxysterols) and their impact on breast cancer chemoresistance and non-alcoholic fatty liver disease. Collaborative Environment: She participates in the strategic research initiative “Integrated technologies for tracking organoid morphogenesis (ITOM)” and is affiliated with the Bio3 research group “Chemical Life Sciences – Biomolecules, Bio-Inspired Materials and Bioanalytical Chemistry”. The group fosters interdisciplinary collaborations bridging chemistry, biology and engineering. No explicit funding details, awards or student lists were present in the supplied material.

Swathi MurthyView profile

Assistant Professor

• Biophotonics
• Biophysics
• Coral Reef Studies
• +13 more

Swathi Murthy serves as an Assistant Professor in the Department of Biology within the Faculty of Science at the University of Copenhagen, specializing in Marine Biology. Her research profile is prominently featured on the university's bio.ku.dk domain, with her office located at Strandpromenaden 5 in Helsingør. She maintains an active research program with numerous recent publications spanning from 2021 to 2025, reflecting her ongoing contributions to marine biophysics and biophotonics. Dr. Murthy's primary research interests focus on biophotonics and biophysics studies of reef-building corals and biofilms. She develops experiment-driven multi-physics numerical models to investigate how corals and biofilms interact with light and hydrodynamics across scales from cellular to organism levels. As a specialist in light-scattering measurements, her technical expertise includes optical coherence tomography, digital holotomography, hyperspectral imaging, and micro-sensor measurements of light, chemical species, and temperature. Her work bridges fundamental science with practical applications, aiming to study functional adaptations in nature that modulate light and chemical environments across length scales from nanometers to meters. Analysis of her recent publications reveals a consistent research trajectory centered on coral microenvironments, bioimaging techniques, and bioprinting applications. Her work demonstrates strong interdisciplinary collaboration, particularly with Michael Kühl and other researchers across multiple institutions. The publications show increasing sophistication in both experimental methods and computational modeling approaches, with recent work expanding into 3D bioprinting of microalgal constructs and advanced light management systems inspired by natural organisms. Dr. Murthy actively participates in multi-disciplinary collaborative projects, with research outputs spanning journal articles, conference proceedings, and preprints. Her work appears in high-impact journals including Proceedings of the National Academy of Sciences, Journal of the Royal Society Interface, and Biotechnology Advances. The citation metrics indicate growing recognition of her contributions, with several publications accumulating significant readership on platforms like Mendeley and social media engagement. Her laboratory work appears to focus on marine organism imaging and microenvironment analysis, with particular emphasis on coral reef systems and photosynthetic organisms. The research has clear applications in nature conservation and restoration efforts, as well as potential translation into sustainable consumer products such as displays and solar cells that take inspiration from natural light management systems.

Dana Cialla-MayView profile

Researcher

• Surface-Enhanced Raman Spectroscopy
• Biosensors
• Biomedical Diagnostics
• +5 more

Dr. Dana Cialla-May serves as a Group Leader in the Research Department of Spectroscopy/Imaging at the Leibniz Institute of Photonic Technology (Leibniz-IPHT) in Jena, Germany, where she heads the Working Group for Plasmon-Enhanced Bioanalytics. Her research program focuses on developing advanced spectroscopic and biosensing technologies for biomedical applications, with particular expertise in Surface-Enhanced Raman Spectroscopy (SERS) and aptamer-based detection systems. Dr. Cialla-May's research spans multiple critical areas of biomedical diagnostics. She specializes in creating plasmon-enhanced bioanalytical methods for point-of-care diagnostic applications, integrating spectroscopic techniques with microfluidic systems to develop novel platforms for drug monitoring, toxin detection, and disease diagnosis. Her work addresses fundamental challenges in SERS technology, particularly regarding reproducibility and stability in complex biological matrices such as blood plasma, tissues, and environmental samples. She has made significant contributions to both the theoretical understanding and practical implementation of these technologies. Analysis of her recent publication trends reveals a cohesive research trajectory focused on multiplexed detection systems for diverse analytes including antibiotics, chemotherapeutic drugs, venoms, and marine biotoxins. Her work demonstrates expertise in both direct and indirect SERS approaches, electrochemical aptasensing techniques, and microphysiological modeling. The consistent publication in high-impact journals across chemistry, biomedical engineering, and analytical science reflects the interdisciplinary nature and significance of her contributions to advancing diagnostic technologies from bench to bedside.

• Cancer Immunotherapy
• CAR T-Cell Therapy
• Theranostics
• +3 more

Dr. Anja Feldmann serves as the Head of the Radioimmunology Department at the Helmholtz-Zentrum Dresden-Rossendorf (HZDR). She leads research in cancer immunotherapy, focusing on modular and switchable CAR T-cell platforms for targeted treatment of solid tumors and hematological malignancies. Her work integrates cutting-edge technologies like biosensors and theranostic tools to enhance therapeutic efficacy and overcome immune escape mechanisms. Her research interests revolve around developing universal chimeric antigen receptor (UniCAR) systems and their adaptability for personalized immunotherapy. Key areas include the design of target modules for CAR T/NK cells, combining immunotherapy with radiation, and creating diagnostic tools such as extended-gate field-effect transistors (FET) biosensors to monitor drug responses. She also explores applications in autoimmune diseases and oncology, emphasizing safety and precision in therapeutic approaches. Dr. Feldmann’s recent advancements include overcoming antigen loss in tumors via dual targeting and improving CAR T-cell persistence through affinity optimization. Her lab’s work on RevCAR systems demonstrates innovation in redirecting T cells to immunosuppressive markers like PD-L1, turning them into activating signals. Despite no explicit mention of scientific awards, her contributions to CAR T-cell engineering and theranostics are highlighted through collaborations and preclinical studies. She oversees projects involving clinical scale manufacturing, off-the-shelf NK cell therapies, and interdisciplinary approaches to cancer management. Her team’s efforts span from lab-scale innovations to translational research, aiming to bridge gaps between diagnostics and treatment.